Paul is a senior leader in the life sciences consulting industry. He was a Partner at Easton Associates LLC, a Managing Director at Navigant, which acquired Easton, and ClearView Healthcare Partners. Paul has led over 800 engagements serving clients from startups to top ten pharmaceutical companies. He has developed the expertise in commercial and BD strategies for pipeline assets, integrating scientific acumen with commercial industry knowhow to generate experience-based, actionable advice to global client management teams. He is also a preeminent expert on the rapidly evolving China market, having built a consulting team in Shanghai and Beijing over the last 10 years, advising clients on China market entry strategies and BD&L approaches. Prior to starting his consulting career with Easton Associates, Paul spent six years in the pharmaceutical industry in preclinical research and pipeline strategy roles at Bristol-Myers Squibb, Knoll Pharmaceuticals and Pharmacia, gaining strong client-side experience. Paul holds an MBA degree from Cornell University’s Johnson School and a M.S. degree in Molecular Biology from Rutgers University. He is also fluent in Mandarin.
President, Board Member, BioKatalyst
Partner, Bluestar BioAdvisors, LLC